An Act to amend and reenact § 9.1-102 of the Code of Virginia, relating to use of confidential informants in drug-related investigations.
HB1140 amends § 9.1-102 of the Code of Virginia, which sets out the powers and duties of the Virginia Department of Criminal Justice Services and the Criminal Justice Services Board. Based on the bill caption, the measure is intended to address the use of confidential informants in drug-related investigations, although the text provided here shows the bill making broader updates to the statute governing law-enforcement training and standards. The section includes numerous training requirements for law-enforcement officers, jail and correctional staff, dispatchers, and other public-safety personnel.
In practical terms, the bill appears to place the issue of confidential informants within the existing framework of criminal justice policy and law-enforcement oversight, rather than creating a separate standalone chapter. Because the provided text is only a partial excerpt of the amended statute, the specific informant-related changes are not visible here; however, the bill clearly operates by amending the state code section that authorizes the Board to set standards, training, and procedures for criminal justice personnel.
The bill amends § 9.1-102 of the Code of Virginia, a central statute governing the Department of Criminal Justice Services and the Criminal Justice Services Board. Any changes made under this section can affect statewide law-enforcement policy, training requirements, and administrative standards for agencies and personnel covered by the statute. Given the bill caption, it also likely affects how confidential informants may be used or regulated in drug-related investigations, potentially influencing investigative practices, oversight, and agency compliance obligations.
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, support, or opposition in the materials supplied. The bill was enacted as Chapter 742 and approved on April 13, 2026, which indicates it ultimately received sufficient legislative support to become law. On that basis, the overall sentiment appears to have been favorable or at least noncontroversial at the final stage, though the absence of discussion records limits any deeper assessment.
The main potential point of contention is the use and regulation of confidential informants in drug-related investigations, a topic that often raises concerns about reliability, accountability, due process, and law-enforcement discretion. Stakeholders who may have differing views include prosecutors and police agencies, who may favor flexible investigative tools, and civil liberties advocates, defense attorneys, or criminal justice reform groups, who may seek stronger safeguards and oversight. Because no hearing transcript or vote breakdown is available, specific objections or amendments cannot be identified from the record provided.